{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:27:04Z","timestamp":1772119624328,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017590","name":"Universit\u00e4tsklinikum Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017590","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>We present the case of a 24-year-old male with CNS granulomatosis due to an immunodeficiency syndrome which was identified as deficiency of adenosine deaminase 2 (DADA2) as a cause of brainstem infarction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Case report and detailed description of the clinical course of diagnosis and treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case<\/jats:title>\n                    <jats:p>The patient\u2019s medical history consisted of an unknown immunodeficiency syndrome. Based on former findings, common variable immunodeficiency (CVID) was diagnosed. The patient suffered from three consecutive brainstem strokes of unknown etiology within 3\u00a0years. An MRI scan detected gadolinium-enhancing, granulomatous-suspect lesions in the interpeduncular cistern, temporal lobe, and tegmentum. Laboratory analysis was compatible with CVID, with leukopenia and immunoglobulin deficiency. Because granulomatous CNS inflammation was suspected, the patient received methylprednisolone immunosuppressive therapy, which led to partially regressive MRI lesions. However, in contrast to imaging, the patient showed a progressive cerebellar syndrome, indicating plasma exchange therapy and immunoglobulin treatment, which led to rapid symptom amelioration. After a relapse and a further stroke, expanded analysis confirmed DADA2 (and not CVID) as the inflammatory cause for recurrent stroke. After starting the therapy with immunoglobulins and adalimumab, no further strokes occurred.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We present the case of a young adult with diagnosis of DADA2 as a cause for recurrent strokes due to vasculitis. This stroke etiology is rare but should be considered as a cause of recurrent stroke of unknown origin in young patients to avoid a disabling disease course by disease-specific treatment options.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10875-023-01526-3","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T05:02:23Z","timestamp":1686546143000},"page":"1597-1602","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Brainstem Infarction in Immunodeficiency Identified as Adenosine Deaminase 2 Deficiency: Case Report"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0683-0430","authenticated-orcid":false,"given":"Christoph","family":"Oster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Stolte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livia","family":"Asan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Refik","family":"Pul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Klebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"K\u00f6hrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Breuckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Rischpler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelius","family":"Deuschl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Dolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Kleinschnitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3631-3450","authenticated-orcid":false,"given":"Tim","family":"Hagenacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,12]]},"reference":[{"issue":"3","key":"1526_CR1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00018-016-2357-0","volume":"74","author":"Y Kaljas","year":"2017","unstructured":"Kaljas Y, et al. Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells. Cell Mol Life Sci. 2017;74(3):555\u201370.","journal-title":"Cell Mol Life Sci"},{"issue":"16","key":"1526_CR2","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1056\/NEJMc1801927","volume":"380","author":"AK Ombrello","year":"2019","unstructured":"Ombrello AK, et al. Treatment strategies for deficiency of adenosine deaminase 2. N Engl J Med. 2019;380(16):1582\u20134.","journal-title":"N Engl J Med"},{"issue":"2","key":"1526_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/art.41500","volume":"73","author":"A Sharma","year":"2021","unstructured":"Sharma A, et al. Deficiency of adenosine deaminase 2 in adults and children: experience from India. Arthritis Rheumatol. 2021;73(2):276\u201385.","journal-title":"Arthritis Rheumatol"},{"key":"1526_CR4","unstructured":"Hoffmann PM, O.A., Stone DL, Follmann D, Barron K, Jones A, Romeo T, Toro C, Soldatos A, Hay A, Zhou Q, Aksentijevich I, Kastner DL. Risk of hemorrhagic strokes in patients with adenosine deaminase 2 deficiency [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https:\/\/acrabstracts.org\/abstract\/risk-of-hemorrhagic-strokes-in-patients-with-adenosine-deaminase-2-deficiency\/. Accessed March 21, 2023."},{"key":"1526_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3389\/fimmu.2014.00415","volume":"5","author":"R Ameratunga","year":"2014","unstructured":"Ameratunga R, et al. Comparison of diagnostic criteria for common variable immunodeficiency disorder. Front Immunol. 2014;5:415.","journal-title":"Front Immunol"},{"issue":"1","key":"1526_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.18176\/jiaci.0388","volume":"30","author":"R Yazdani","year":"2020","unstructured":"Yazdani R, et al. Common variable immunodeficiency: epidemiology, pathogenesis, clinical manifestations, diagnosis, classification, and management. J Investig Allergol Clin Immunol. 2020;30(1):14\u201334.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"2","key":"1526_CR7","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jaci.2012.10.029","volume":"131","author":"M Martinez-Gallo","year":"2013","unstructured":"Martinez-Gallo M, et al. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes. J Allergy Clin Immunol. 2013;131(2):468\u201376.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1526_CR8","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s10875-012-9717-9","volume":"32","author":"N Kutukculer","year":"2012","unstructured":"Kutukculer N, et al. Three different classifications, B lymphocyte subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms in Turkish patients with common variable immunodeficiency. J Clin Immunol. 2012;32(6):1165\u201379.","journal-title":"J Clin Immunol"},{"issue":"4","key":"1526_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.18176\/jiaci.0069","volume":"26","author":"G Azizi","year":"2016","unstructured":"Azizi G, et al. T-cell abnormalities in common variable immunodeficiency. J Investig Allergol Clin Immunol. 2016;26(4):233\u201343.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"1","key":"1526_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2500\/aap.2020.41.190012","volume":"41","author":"FA Bonilla","year":"2020","unstructured":"Bonilla FA. Personalized therapy for common variable immunodeficiency. Allergy Asthma Proc. 2020;41(1):19\u201325.","journal-title":"Allergy Asthma Proc"},{"issue":"3","key":"1526_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/cei.12915","volume":"188","author":"S Jolles","year":"2017","unstructured":"Jolles S, Chapel H, Litzman J. When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach. Clin Exp Immunol. 2017;188(3):333\u201341.","journal-title":"Clin Exp Immunol"},{"key":"1526_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jns.2015.12.001","volume":"361","author":"Y Nakano","year":"2016","unstructured":"Nakano Y, et al. Two young stroke patients associated with regular intravenous immunoglobulin (IVIg) therapy. J Neurol Sci. 2016;361:9\u201312.","journal-title":"J Neurol Sci"},{"issue":"2","key":"1526_CR13","doi-asserted-by":"publisher","first-page":"240 e13","DOI":"10.1016\/j.avsg.2012.09.003","volume":"27","author":"N Skeik","year":"2013","unstructured":"Skeik N, et al. Concurrent Takayasu arteritis with common variable immunodeficiency and moyamoya disease. Ann Vasc Surg. 2013;27(2):240 e13-8.","journal-title":"Ann Vasc Surg"},{"issue":"3","key":"1526_CR14","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jaip.2019.11.039","volume":"8","author":"A van de Ven","year":"2020","unstructured":"van de Ven A, et al. Structural noninfectious manifestations of the central nervous system in common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2020;8(3):1047-1062 e6.","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01526-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-023-01526-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01526-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T04:08:10Z","timestamp":1694578090000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-023-01526-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,12]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1526"],"URL":"https:\/\/doi.org\/10.1007\/s10875-023-01526-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2418177\/v1","asserted-by":"object"}]},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,12]]},"assertion":[{"value":"12 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this case report no approval was needed by the Ethics Committee because no study was performed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that the patient provided informed consent for publication of the data and the images in Figs.\u00a0\n                      \n                      A, B,\n                      \n                      A, B and\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}